Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-24 @ 6:24 AM
Study NCT ID:
NCT04178057
Status:
UNKNOWN
Last Update Posted:
2019-11-27
First Post:
2019-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Sponsor:
Genor Biopharma Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain Tumor | View |
Keywords: